Consumables
3M Licenses Dry Powder Inhaler Technology from Cambridge Consultants
Thursday 11. December 2008 - 3M Drug Delivery Systems announces the signing of an exclusive technology license and purchase agreement with Cambridge Consultants for its ConixTM Dry Powder Inhaler (DPI) technology platform.
The Conix DPI technology, also called reverse-flow cyclone technology, adds to 3Ms extensive inhalation technology platform.
“This new technology platform enhances 3Ms capability to provide partner pharmaceutical and biotechnology companies with innovative drug delivery solutions,” said James Vaughan, division vice president, 3M Drug Delivery Systems Division. “We believe the Conix technology will add to the breadth of our unique inhalation technology portfolio and enables us to offer new and exciting drug delivery alternatives.”
The Conix technology platform includes a variety of inhaler types, ranging from a single dose device suitable for applications such as immunizations, to a multi-unit dose suitable for routine therapies, such as, asthma and COPD.
3M Drug Delivery Systems has more than 50 years of experience and proven success in inhalation technologies. 3M offers a full range of inhalation technology platforms from pressurized metered-dose inhalers (pMDI) to components – including cans, valves and dose counters.